1.00 pm - 3.00 pm GMT
(2.00 pm - 4.00 pm CEST)
Do you want to get an overview of the Corona pandemic with a clear mandate to differentiate facts from emotional, “half-news” or even fake news.
Are you looking for a guidance for a better understanding of possible implications for insurance industry, particularly life insurance?
If yes, the EAA invite you to join our webinar: Novel Coronavirus - the Next Big Pandemic? Medical and Epidemiological Aspects - The Facts and What to Expect Next
The webinar is open to all interested persons working within the insurance industry.
A novel coronavirus (SARS-CoV-2) originated in 2019 in Wuhan, China. A new coronavirus not previously identified in humans, the virus causes COVID-19 disease, a highly transmittable disease - primarily via close person-to-person contact - that also displays varied severity and symptoms, challenging attempts to limit its spread.
Please check with your IT department if your firewall and computer settings support webinar participations (the programme GoToTraining is used for the webinar). Please also make sure that you are joining the webinar with a stable internet connection.
On 23 March April 2020 9:00 am - 10:00 am (10:00 – 10:30 CEST) there will be a test session offered to all registered participants to test the software.
The registration fee is € 100.00 plus 19 % VAT.
Please register for the webinar by using our online registration form at www.actuarial-academy.com as soon as possible because of the expected demand. If there are more persons interested than places available we will give priority to the registrations received first. After your registration, you will receive further log-in details to join the webinar. There will be a test session before the webinar.
Your registration is binding. Cancellation is only possible up to 2 weeks before the first day of the event. If you cancel at a later date, the full participation fee is due. You may appoint someone to take your place, but must notify us in advance. EAA has the right to cancel the event if the minimum number of participants is not reached.
In this webinar, Achim Regenauer, Chief Medical Officer of PartnerRe, presents the facts as we know them now, covering the key medical and epidemiological aspects relevant to the insurance industry.
The aim of this webinar is to provide an overview of the Corona pandemic with a clear mandate to differentiate facts from emotional, “half-news” or even fake news. It should also offer guidance for a better understanding of possible implications for insurance industry, particularly life insurance.
- COVID-19, MERS, SARS and influenza
- What are the differences? - Is this already a pandemic?
- The virus’ profile - COVID-19 medical aspects (symptoms)
- Transmissibility - R0 and CFR
- Underlying data and how to interpret the current figures
- Testing options, role of genomics and impact on epidemiological understanding
- Is containment effective?
- Treatment – where are we now?
- Mysteries of COVID-19
Dr. Achim Regenauer is a specialist in internal medicine with many years of experience in clinical medicine before joining reinsurance industry. Over several decades he has acquired knowledge in risk management of international life insurance (case assessment, development of guidelines, various forms and depths of underwriting, coaching, product counselling, claims, complaint management), partially also in the health and non-life areas of insurance.
Dr. Regenauer worked internationally for Munich Re at an executive level with additional engagements in various insurance associations (e.g. Board Member of the ICLAM and Chairman of the board of Department for Life Insurance Medicine in Germany), but also with frequent contact to actuarial organisations, governments and the media dealing with hot topics such as SARS and Avian influenza. In the last years one of his major task has been to monitor and to analyze non-financial trends in medicine, technology, society and politics in terms of their impact on life and health insurance. As from January 1, 2017 he joined PartnerRe as Chief Medical Officer dealing with emerging topics such as pandemics, antimicrobial resistance, obesity etc. Major focus areas of his activities are longevity issues, underwriting, claims, critical illness, critical advantage, e-health and regular updates on Partner Re`s manual PAR (underwriting manual).